Hepatocellular carcinoma, the most common primary cancer of the liver, may become more vulnerable to treatment through a molecular pathway...

Cancer clinical trials are entering an era in which artificial intelligence could influence nearly every stage of the research process,...

HOUSTON—Researchers at Baylor College of Medicine and collaborating institutions have identified a previously unrecognized weakness in acute myeloid leukemia (AML),...

A new editorial notice in the British Journal of Cancer has placed a formal question mark over a study that...

A new review in Experimental & Molecular Medicine is drawing attention to the gut–liver axis as one of the body’s...

Pancreatic cancer has long been described as a disease protected by its surroundings. Rather than existing as an isolated mass...

For patients with advanced head and neck cancer, the race against time does not end when a tumor is removed....

For women living with metastatic breast cancer, a smartphone app may offer more than convenience: it can function as a...

Gastric cancer remains one of the world’s most lethal malignancies, and its treatment is increasingly threatened by resistance to cisplatin,...

Oklahoma researchers have received a five-year, $2 million grant from the National Cancer Institute to investigate how pancreatic cancer alters...